首页> 外文期刊>Biomaterials >Preparation and blood compatibility of polysiloxane/liquid-crystal composite membranes.
【24h】

Preparation and blood compatibility of polysiloxane/liquid-crystal composite membranes.

机译:聚硅氧烷/液晶复合膜的制备及其血液相容性。

获取原文
获取原文并翻译 | 示例
           

摘要

Polysiloxane/liquid crystal composite membrane was first suggested to be used as biomaterials. In this work, the polydimethyl-methylhydrosiloxane and polydimethyl-methylethylenesilosiane, as a substrate, were blended with cholesteryl oleyl carbonate (COC) in tetrahydrofuran, and then crosslinked into membranes on glass plates by means of the platinum catalyst at 110 degrees C for 20 min. The effects of the liquid-crystal content in composite membranes on the formation of liquid-crystal phase were verified by the observation of optical polarization microscopy. The relationship between the morphology of the composite membranes and blood compatibility was identified by the dynamic blood-clotting tests, haemolysis ratio measurement, platelet adhesion and SEM observation. The results show that the blood-compatibility of composite membranes with the concentration of liquid crystal 20, 30% (wt) is more excellent than that of other composite membranes.
机译:最早提出将聚硅氧烷/液晶复合膜用作生物材料。在这项工作中,将聚二甲基-甲基氢硅氧烷和聚二甲基-甲基亚乙基硅烷基硅烷作为底物与胆固醇碳酸酯(COC)在四氢呋喃中共混,然后在110℃下借助铂催化剂在玻璃板上交联成膜20分钟。 。通过光学偏振显微镜的观察证实了复合膜中液晶含量对液晶相形成的影响。通过动态凝血试验,溶血比测定,血小板粘附和SEM观察来鉴定复合膜的形态与血液相容性之间的关系。结果表明,液晶浓度为20%,30%(wt)的复合膜的血液相容性优于其他复合膜。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号